Erratum: Transport of a hydrophilic paclitaxel derivative, 7-xylosyl-10- deacetylpaclitaxel, by human intestinal epithelial caco-2 cells (Planta Medica (2010) DOI: 10.1055/s-0030-1249836);Transport of a hydrophilic paclitaxel derivative, 7-xylosyl-10- deacetylpaclitaxel, by human intestinal epithelial caco-2 cells

Planta Medica

Volumn 76, Issue 14, 2010, Pages 1592-1595

  Jiang, Shougang ^a   Zu, Yuangang ^a   Zhang, Yu ^a   Fu, Yujie ^a   Wang, Zhuo ^a   Wang, Jingtao ^a,b  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

Author keywords

7xylosyl10deacetylpaclitaxel; absorption Pglycoprotein; Caco2; Taxaceae; Taxus cuspidate

Indexed keywords

7 XYLOSYL 10 DEACTYLPACLITAXEL; PACLITAXEL DERIVATIVE; TETRANDRINE; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CELL STRAIN CACO 2; DRUG ABSORPTION; DRUG BIOAVAILABILITY; HUMAN; HUMAN CELL; HYDROPHILICITY; INTESTINE EPITHELIUM;

TAXACEAE; TAXUS;

EID: 77957562674     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250251     Document Type: Erratum

References (24)

1. Fu Y, Li S, Zu Y, Yang G, Yang Z, Luo M, Jiang S, Wink M, Efferth T. Medicinal chemistry of paclitaxel and its analogues. Curr Med Chem 2009 16 3966-3985
2. Hennenfent K L., Govindan R. Novel formulations of taxanes: a review. Old wine in a new bottle Ann Oncol 2006 17 735-749
3. Fu Y, Zu Y, Li S, Sun R, Efferth T, Liu W, Jiang S, Luo H, Wang Y. Separation of 7-xylosyl-10-deacetyl-paclitaxel and 10-deacetylbaccatin III from the remainder extracts free of paclitaxel using macroporous resins. J Chromatogr A 2008 1177 77-86 (Pubitemid 350256748)
4. Parmar V S., Jha A, Bisht K S., Taneja P, Singh S K., Kumar A, Poonam J R., Olsen C E. Constituents of the yew trees. Phytochemistry 1999 50 1267-1304 (Pubitemid 29204907)
5. Jiang S G., Zu Y G., Fu Y J., Zhang Y, Efferth T. Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel. Int J Oncol 2008 33 103-111
6. Jiang S G., Zu Y G., Zhang L, Zhang Y, Wang Z, Hua X, Wang J T. Determination of a hydrophilic paclitaxel derivative, 7-xylosyl-10- deacetylpaclitaxel in rat plasma by LCMS/MS. Biomed Chromatogr 2009 23 472-479
7. Li Y, Shin Y G., Yu C, Kosmeder J W., Hirschelman W H., Pezzuto J M., van Breemen R B. Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Comb Chem High Throughput Screen 2003 6 757-767 (Pubitemid 38017483)
8. Krger P, Kanzer J, Hummel J, Fricker G, Schubert-Zsilavecz M, Abdel-Tawab M. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2. Eur J Pharm Sci 2009 36 275-284
9. Senilh V, Blechert S, Colin M, Guenard D, Picot F, Potier P, Varenne P. Mise en evidence de nouveaux analogues du taxol extraits de Taxus baccata. J Nat Prod 1984 47 131-137 (Pubitemid 14168006)
10. Jovov B, Wills N K., Lewis S A. A spectroscopic method for assessing confluence of epithelial cell cultures. Am J Physiol 1991 261 C1196-C1203
11. Walle U K., Walle T. Taxol transport by human intestinal epithelial Caco-2 cells. Drug Metab Dispos 1998 26 343-346 (Pubitemid 28201244)
12. Choi S U., Park S H., Kim K H., Choi E J., Kim S, Park W K., Zhang Y H., Kim H S., Jung N P., Lee C O. The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein. Anticancer Drugs 1998 9 255-261 (Pubitemid 28186523)
13. Liu Z L., Hirano T, Tanaka S, Onda K, Oka K. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. J Pharm Pharmacol 2003 55 1531-1537 (Pubitemid 37441359)
14. Gao J, Hugger E D., Beck-Westermeyer M S., Borchardt R T. Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayers. Current protocols in pharmacology. Chichester John Wiley & Sons, Inc. 2000 1-23
15. Fossati L, Dechaume R, Hardillier E, Chevillon D, Prevost C, Bolze S, Maubon N. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs. Int J Pharm 2008 360 148-155
16. Sun H, Chow E C., Liu S, Du Y, Pang K S. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin Drug Metab Toxicol 2008 4 395-411 (Pubitemid 351728514)
17. Del-Amo E M., Heikkinen A T., Mnkknen J. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption. Eur J Pharm Sci 2009 36 200-211
18. Press B, Di Grandi D. Permeability for intestinal absorption: Caco-2 assay and related issues. Curr Drug Metab 2008 9 893-900
19. Chen Y J. Potential role of tetrandrine in cancer therapy. Acta Pharmacol Sin 2002 23 1102-1106 (Pubitemid 35470334)
20. Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, Yang X, Pan Q. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Chemother Pharmacol 2004 53 349-356 (Pubitemid 38392360)
21. Fu L W., Zhang Y M., Liang Y J., Yang X P., Pan Q C. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur J Cancer 2002 38 418-426
22. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man fact or myth. Pharm Res 1997 14 763-766 (Pubitemid 27281671)
23. Spratlin J, Sawyer M B. Pharmacogenetics of paclitaxel metabolism. Crit Rev Oncol Hematol 2007 61 222-229 (Pubitemid 46329429)
24. Cheng K C., Li C, Uss A S. Prediction of oral drug absorption in humans from cultured cell lines and experimental animals. Expert Opin Drug Metab Toxicol 2008 4 581-590 (Pubitemid 351890740)